Aarti Drugs Limited — Others, 07-02-2025: Action(s) taken or orders passed

Aarti Drugs has received an order from the CGST & C.Ex. Authority concerning a demand for an erroneous IGST refund of ₹20.72 crore, alongside an imposed penalty of the same amount. The authority dropped a separate demand of ₹209.98 crore linked to earlier assessments. The company alleges violations related to IGST for FY 2017-18 to FY 2021-22 but considers the likelihood of these demands materializing as liabilities to be low. Aarti Drugs plans to appeal the order, and the financial impact remains uncertain pending further adjudication. Investors might view this situation as presenting potential risks, yet management's proactive approach could indicate a positive outlook.